A detailed history of Bearing Point Capital, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Bearing Point Capital, LLC holds 3,965 shares of ABT stock, worth $515,568. This represents 0.09% of its overall portfolio holdings.

Number of Shares
3,965
Previous 4,065 2.46%
Holding current value
$515,568
Previous $553 Million 3.94%
% of portfolio
0.09%
Previous 0.1%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

SELL
$120.51 - $136.62 $12,051 - $13,662
-100 Reduced 2.46%
3,965 $531 Million
Q2 2025

Aug 07, 2025

BUY
$123.95 - $138.08 $24,294 - $27,063
196 Added 5.07%
4,065 $553 Million
Q1 2025

May 07, 2025

BUY
$111.1 - $140.22 $15,998 - $20,191
144 Added 3.87%
3,869 $513 Million
Q4 2024

Feb 14, 2025

BUY
$111.93 - $119.39 $416,939 - $444,727
3,725 New
3,725 $421 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $228B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Bearing Point Capital, LLC Portfolio

Follow Bearing Point Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bearing Point Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bearing Point Capital, LLC with notifications on news.